Latest news and press releases about Kenvue Inc. (KVUE): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec.
Price
| Price | $17.39 |
| Market Cap | $33.4B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 19.77 |
| Price / Book | 3.13 |
| EV / EBITDA | 13.77 |
| Dividend Yield | 6.06% |
Profitability
| Return on Equity | 13.66% |
| Return on Invested Capital | 8.80% |
| Return on Assets | 5.43% |
| Gross Margin | 58.19% |
| Operating Margin | 19.52% |
| Net Margin | 10.76% |
Related companies: ADM · CHD · EL · HSY · JBS · K · KDP
Explore sector: Consumer Defensive · Household & Personal Products
More sections of KVUE: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks